Document Detail


Absolute and Relative Changes (Delta) in Troponin I for Early Diagnosis of Myocardial Infarction: Results of a Prospective Multicenter Trial.
MedLine Citation:
PMID:  25261587     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
OBJECTIVES: We investigated absolute and relative cardiac troponin I (TnI) delta changes, optimal sampling protocols, and decision thresholds for early diagnosis of myocardial infarction (MI). Serial cardiac biomarker values demonstrating a rise and/or fall define MI diagnosis; however the magnitude of change, timing, and diagnostic accuracy of absolute versus relative (percentage) deltas remains unsettled.
METHODS: We prospectively measured TnI (AccuTnI+3™, Beckman Coulter) at serial time intervals in 1,929 subjects with chest pain or equivalent symptoms of acute coronary syndrome at 14 medical centers. Diagnosis was adjudicated by an independent central committee.
RESULTS: Elevated TnI above a threshold of 0.03ng/mL demonstrated significant diagnostic efficacy (AUC 0.96). For patients with TnI <0.03ng/mL and symptom onset ≥8h, 99.1% (NPV) were diagnosed with conditions other than MI. Absolute delta performed significantly better than relative delta at 1-3h (AUC 0.84 vs 0.69), 3-6h (0.85 vs 0.73), and 6-9h (0.91 vs 0.79). Current recommendations propose ≥20% delta within 3-6h; however, results were optimized using an absolute delta of 0.01 or 0.02ng/mL. Sensitivity results for absolute delta at 1-3h and 3-6h (75.8%, 78.3%) were superior to relative delta (48.0%, 61.3%). NPV (rule out) was 99.6% when baseline TnI<0.03ng/mL and absolute delta TnI<0.01ng/mL.
CONCLUSIONS: Absolute delta performed significantly better than relative delta at all time intervals. Baseline TnI and absolute delta may be used in conjunction to estimate probability of MI. Consensus recommendations are supported for sampling on admission and 3h later, repeated at 6h in patients when clinical suspicion remains high.
Authors:
Alan B Storrow; Richard M Nowak; Deborah B Diercks; Adam J Singer; Alan H B Wu; Erik Kulstad; Frank LoVecchio; Christian Fromm; Gary Headden; Tracie Potis; Christopher J Hogan; Jon W Schrock; Daniel P Zelinski; Marna R Greenberg; Robert H Christenson; James C Ritchie; Janna S Chamberlin; Kurtis R Bray; Daniel W Rhodes; Deirdre Trainor; Paula C Southwick
Related Documents :
8753677 - Myocardial infarction in rats: high-resolution single-photon emission tomographic imagi...
18762777 - Role of kallistatin in prevention of cardiac remodeling after chronic myocardial infarc...
3471897 - Serotonin reduces coronary flow in the isolated heart of the spontaneously hypertensive...
10749707 - Heterogeneous cardiac sympathetic innervation in heart failure after myocardial infarct...
7586367 - Chronic inhibition of endothelium-derived nitric oxide synthesis causes coronary microv...
22421737 - Cardiac remodeling is not modulated by overexpression of muscle lim protein (mlp).
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-9-24
Journal Detail:
Title:  Clinical biochemistry     Volume:  -     ISSN:  1873-2933     ISO Abbreviation:  Clin. Biochem.     Publication Date:  2014 Sep 
Date Detail:
Created Date:  2014-9-27     Completed Date:  -     Revised Date:  2014-9-28    
Medline Journal Info:
Nlm Unique ID:  0133660     Medline TA:  Clin Biochem     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2014 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Comparison of tandem mass spectrometry and amino acid analyzer for phenylalanine and tyrosine monito...
Next Document:  Proper interpretation of chronic toxicity studies and their statistics: A critique of "Which level o...